LifeStance holders back directors, pay, auditor
LifeStance Health Group, Inc. held its annual stockholder meeting on June 2, 2026.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. held its annual stockholder meeting on June 2, 2026. Stockholders elected Class II directors David Bourdon and Robert Bessler to three-year terms, with 244,968,319 and 280,015,618 votes cast for their elections, respectively.
Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ended December 31, 2026, with 357,756,707 votes for the proposal. In addition, stockholders approved, on a non-binding advisory basis, the company’s named executive officer compensation, with 322,904,359 votes in favor.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for David Bourdon: 244,968,319 votes
Votes for Robert Bessler: 280,015,618 votes
Auditor ratification votes for PwC: 357,756,707 votes
+4 more
7 metrics
Votes for David Bourdon
244,968,319 votes
Election as Class II director at June 2, 2026 annual meeting
Votes for Robert Bessler
280,015,618 votes
Election as Class II director at June 2, 2026 annual meeting
Auditor ratification votes for PwC
357,756,707 votes
Ratification of PricewaterhouseCoopers LLP for year ended December 31, 2026
Auditor ratification votes against
209,431 votes
Ratification of PricewaterhouseCoopers LLP for 2026
Advisory say-on-pay votes for
322,904,359 votes
Non-binding advisory vote on named executive officer compensation
Advisory say-on-pay votes against
5,675,861 votes
Non-binding advisory vote on named executive officer compensation
Broker non-votes on say-on-pay
29,782,714 votes
Non-binding advisory vote on named executive officer compensation
Key Terms
broker non-votes, independent registered public accounting firm, non-binding advisory basis, named executive officer compensation, +1 more
5 terms
broker non-votes financial
"Broker Non-Votes 322,904,359 | | 5,675,861 | | 354,151 | | 29,782,714"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
non-binding advisory basis financial
"approved, on a non-binding advisory basis, the Company’s named executive officer compensation"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
named executive officer compensation financial
"advisory basis, the Company’s named executive officer compensation. The results of the vote were as follows"
Pay and benefits disclosed for a company’s top executives identified in regulatory filings, including salary, bonuses, stock awards, option grants, pension contributions and other perks. Think of it as a public paycheck summary for senior managers that shows how they are rewarded and motivated. Investors use it to judge whether executive incentives align with shareholder interests, to assess potential costs and risks, and to evaluate corporate governance.
emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LifeStance Health Group (LFST) stockholders approve at the 2026 annual meeting?
Stockholders approved all three proposals: election of two Class II directors, ratification of PricewaterhouseCoopers LLP as auditor for 2026, and a non-binding advisory vote approving named executive officer compensation for the company’s leadership team.
Which directors were elected at LifeStance Health Group’s 2026 annual meeting?
Stockholders elected David Bourdon and Robert Bessler as Class II directors for three-year terms. Bourdon received 244,968,319 votes for his election, while Bessler received 280,015,618 votes for his election to the board of directors.
Did LifeStance Health Group (LFST) stockholders ratify the company’s auditor for 2026?
Yes. Stockholders ratified PricewaterhouseCoopers LLP as LifeStance Health Group’s independent registered public accounting firm for the year ended December 31, 2026, with 357,756,707 votes for, 209,431 against, and 750,947 abstentions recorded.
How did LifeStance Health Group (LFST) stockholders vote on executive compensation?
Stockholders approved the company’s named executive officer compensation on a non-binding advisory basis. The proposal received 322,904,359 votes for, 5,675,861 votes against, 354,151 abstentions, and 29,782,714 broker non-votes at the annual meeting.
Were there broker non-votes at LifeStance Health Group’s 2026 annual meeting?
Yes. Broker non-votes were recorded on proposals that required discretionary voting authority. For example, the advisory vote on named executive officer compensation reported 29,782,714 broker non-votes alongside the for, against, and abstain tallies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
